Literature DB >> 19340503

Effects of bone anabolic agents on bone ultrastructure.

B Cortet1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19340503     DOI： 10.1007/s00198-009-0862-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  7 in total

1.  Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment.

Authors:  Barbara M Misof; Paul Roschger; Felicia Cosman; Etah S Kurland; Walter Tesch; Phaedra Messmer; David W Dempster; Jeri Nieves; Elizabeth Shane; Peter Fratzl; Klaus Klaushofer; John Bilezikian; Robert Lindsay
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

2.  Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.

Authors:  Delphine Farlay; Georges Boivin; Gérard Panczer; Agnès Lalande; Pierre Jean Meunier
Journal:  J Bone Miner Res       Date:  2005-04-27       Impact factor: 6.741

3.  Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration.

Authors:  G Boivin; P Deloffre; B Perrat; G Panczer; M Boudeulle; Y Mauras; P Allain; Y Tsouderos; P J Meunier
Journal:  J Bone Miner Res       Date:  1996-09       Impact factor: 6.741

4.  Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial.

Authors:  Eleftherios P Paschalis; Emmett V Glass; David W Donley; Erik F Eriksen
Journal:  J Clin Endocrinol Metab       Date:  2005-05-24       Impact factor: 5.958

5.  Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.

Authors:  Peiqi Chen; Paul D Miller; Robert Recker; Heinrich Resch; Asad Rana; Imre Pavo; Adrien A Sipos
Journal:  J Bone Miner Res       Date:  2007-08       Impact factor: 6.741

6.  Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study.

Authors:  Patrick Garnero; Doug C Bauer; Emmanuel Mareau; John P Bilezikian; Susan L Greenspan; Clifford Rosen; Dennis Black
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

7.  Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength.

Authors:  Patrick Ammann; Isabelle Badoud; Sébastien Barraud; Romain Dayer; René Rizzoli
Journal:  J Bone Miner Res       Date:  2007-09       Impact factor: 6.741
  7 in total
  2 in total

1.  A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone.

Authors:  J A Siddiqui; G Swarnkar; K Sharan; B Chakravarti; A K Gautam; P Rawat; M Kumar; V Gupta; L Manickavasagam; A K Dwivedi; R Maurya; N Chattopadhyay
Journal:  Osteoporos Int       Date:  2011-01-12       Impact factor: 4.507

Review 2.  Epigenetic regulation of bone remodeling by natural compounds.

Authors:  Nishikant Raut; Sheila M Wicks; Tempitope O Lawal; Gail B Mahady
Journal:  Pharmacol Res       Date:  2019-07-14       Impact factor: 7.658
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.